Craig Bijou
Stock Analyst at B of A Securities
(3.76)
# 716
Out of 5,152 analysts
70
Total ratings
58.97%
Success rate
51.7%
Average return
Main Sectors:
Stocks Rated by Craig Bijou
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PRCT PROCEPT BioRobotics | Downgrades: Underperform | $38 → $20 | $25.35 | -21.10% | 6 | Feb 26, 2026 | |
| GEHC GE HealthCare Technologies | Maintains: Neutral | $82 → $92 | $77.11 | +19.31% | 3 | Jan 5, 2026 | |
| GMED Globus Medical | Upgrades: Buy | $65 → $91 | $89.29 | +1.92% | 5 | Nov 7, 2025 | |
| RXST RxSight | Maintains: Underperform | $18 → $9 | $7.81 | +15.24% | 2 | Jul 9, 2025 | |
| TFX Teleflex | Downgrades: Underperform | $235 → $140 | $117.57 | +19.08% | 5 | Mar 4, 2025 | |
| BLCO Bausch + Lomb | Maintains: Underperform | $18 → $17 | $17.60 | -3.41% | 3 | Feb 20, 2025 | |
| IART Integra LifeSciences Holdings | Maintains: Underperform | $26 → $18 | $9.89 | +82.00% | 13 | Oct 7, 2024 | |
| ITGR Integer Holdings | Maintains: Buy | $135 → $145 | $85.23 | +70.13% | 3 | Oct 1, 2024 | |
| MMSI Merit Medical Systems | Maintains: Neutral | $92 → $103 | $73.49 | +40.16% | 3 | Sep 16, 2024 | |
| HAE Haemonetics | Initiates: Neutral | $85 | $64.23 | +32.34% | 1 | Sep 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $95 | $80.20 | +18.45% | 1 | Oct 30, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $43 → $36 | $14.07 | +155.86% | 2 | Jan 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $23 → $45 | $9.99 | +350.45% | 3 | May 13, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $15 → $120 | $10.73 | +1,018.36% | 2 | Mar 25, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $60 → $30 | $7.60 | +295.00% | 5 | Mar 24, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $8.5 → $6.5 | $12.62 | -48.49% | 2 | Mar 24, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $48 → $42 | $12.57 | +234.13% | 3 | Feb 25, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $207 → $230 | $496.70 | -53.69% | 1 | Jan 10, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $190 → $230 | $370.50 | -37.92% | 4 | Jul 26, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $10.07 | - | 3 | Dec 4, 2017 |
PROCEPT BioRobotics
Feb 26, 2026
Downgrades: Underperform
Price Target: $38 → $20
Current: $25.35
Upside: -21.10%
GE HealthCare Technologies
Jan 5, 2026
Maintains: Neutral
Price Target: $82 → $92
Current: $77.11
Upside: +19.31%
Globus Medical
Nov 7, 2025
Upgrades: Buy
Price Target: $65 → $91
Current: $89.29
Upside: +1.92%
RxSight
Jul 9, 2025
Maintains: Underperform
Price Target: $18 → $9
Current: $7.81
Upside: +15.24%
Teleflex
Mar 4, 2025
Downgrades: Underperform
Price Target: $235 → $140
Current: $117.57
Upside: +19.08%
Bausch + Lomb
Feb 20, 2025
Maintains: Underperform
Price Target: $18 → $17
Current: $17.60
Upside: -3.41%
Integra LifeSciences Holdings
Oct 7, 2024
Maintains: Underperform
Price Target: $26 → $18
Current: $9.89
Upside: +82.00%
Integer Holdings
Oct 1, 2024
Maintains: Buy
Price Target: $135 → $145
Current: $85.23
Upside: +70.13%
Merit Medical Systems
Sep 16, 2024
Maintains: Neutral
Price Target: $92 → $103
Current: $73.49
Upside: +40.16%
Haemonetics
Sep 11, 2024
Initiates: Neutral
Price Target: $85
Current: $64.23
Upside: +32.34%
Oct 30, 2023
Initiates: Buy
Price Target: $95
Current: $80.20
Upside: +18.45%
Jan 18, 2022
Maintains: Buy
Price Target: $43 → $36
Current: $14.07
Upside: +155.86%
May 13, 2020
Reiterates: Overweight
Price Target: $23 → $45
Current: $9.99
Upside: +350.45%
Mar 25, 2020
Maintains: Overweight
Price Target: $15 → $120
Current: $10.73
Upside: +1,018.36%
Mar 24, 2020
Maintains: Neutral
Price Target: $60 → $30
Current: $7.60
Upside: +295.00%
Mar 24, 2020
Reiterates: Overweight
Price Target: $8.5 → $6.5
Current: $12.62
Upside: -48.49%
Feb 25, 2020
Maintains: Neutral
Price Target: $48 → $42
Current: $12.57
Upside: +234.13%
Jan 10, 2020
Reiterates: Overweight
Price Target: $207 → $230
Current: $496.70
Upside: -53.69%
Jul 26, 2019
Maintains: Neutral
Price Target: $190 → $230
Current: $370.50
Upside: -37.92%
Dec 4, 2017
Downgrades: Market Perform
Price Target: n/a
Current: $10.07
Upside: -